Skip to main content

Table 7 Estimates of effective dose in the study centres for the different age groups

From: Estimation of lifetime attributable risk incidence and mortality for breast cancer attributed to computed tomography of the head in the Niger Delta Region of Nigeria

 

Mean effective dose mSv

Age at exposure (years)

Centre G1

Centre G2

20–29

6.82

1.63

30–39

5.63

1.56

40–49

4.88

1.58

50–59

5.43

1.49

60–69

4.25

1.45

70–79

7.92

1.63

80–89

5.42

1.43

Overall

5.76

1.54